iTherx Pharmaceuticals Obtains $3,173,595 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b4a345e3-864a-4d1a-aa7f-f67e33cb3b9c&Preview=1 -
Date
11/7/2011 -
Company Name
iTherx Pharmaceuticals -
Mailing Address
14090 Caminito Vistana San Diego, CA 92130 -
Company Description
iTherX is a clinical stage pharmaceutical company focused on the discovery and development of innovative treatments for Hepatitis C. This is a disease that affects almost 3% of the world’s population, and is the major cause of chronic liver disease, cirrhosis, liver failure and primary liver cancer. -
Website
http://www.itherx.com -
Transaction Type
Venture Equity -
Transaction Amount
$3,173,595 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
